Yakob Liawatidewi - 11 May 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
11 May 2021
Net transactions value
-$166,039
Form type
4
Filing time
13 May 2021, 18:39:37 UTC
Next filing
18 May 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $113,300 +10,000 +16% $11.33* 71,351 11 May 2021 Direct
transaction AMPH Common Stock Sale $190,597 -10,000 -14% $19.06 61,351 11 May 2021 Direct F1
transaction AMPH Common Stock Sale $88,742 -4,592 -7.5% $19.33 56,759 12 May 2021 Direct F2
holding AMPH Common Stock 2,459 11 May 2021 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -10,000 -51% $0.000000 9,637 11 May 2021 Common Stock 10,000 $11.33 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.05 to $19.165 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.31 to $19.373, inclusive.
F3 The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
F4 Shares subject to the option are fully vested and immediately exercisable.